Skip to main content
Premium Trial:

Request an Annual Quote

FDA Grants Emergency Use Authorization for Inform Diagnostics Coronavirus Test

NEW YORK — The US Food and Drug Administration on Friday granted Emergency Use Authorization for a PCR-based SARS-CoV-2 test developed by Inform Diagnostics.

The company's SARS-CoV-2 RT-PCR Assay, which is based on the US Centers for Disease Control and Prevention's CDC 2019-nCoV Real-Time RT-PCR panel, is designed to detect two regions of the virus' nucleocapsid gene in nasopharyngeal, oropharyngeal, anterior nasal, and midturbinate nasal swabs, as well as nasopharyngeal wash/aspirate or nasal aspirates and bronchoalveolar lavage specimens.

Nucleic acid purification is performed using Millipore Sigma's ViralXpress DNA/RNA Extraction Reagent and the test runs on Thermo Fisher Scientific's Applied Biosystems 7500 Fast Dx Real-Time PCR instrument.

The assay may only be performed at Phoenix, Arizona-based Inform, according to the FDA. The company provides anatomic pathology services, including dermatopathology, gastrointestinal pathology, hematopathology, breast pathology, and urologic pathology.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.